Inventor · disambiguated record
Daniel T. Connolly
Also filed as: CONNOLLY DANIEL · CONNOLLY DANIEL T
13 granted patents·17 pending applications·486 citations·filing 1986–2010
93Inventor score
Top patents by PatentIndex Score
30 records- 0193US5240848ADna sequences encoding human vascular permeability factor having 189 amino acidsMONSANTO CO·Filed 1989·Granted Aug 31, 1993·197 cites·8 claims
- 0291US5036003AAntibodies to VPFMONSANTO CO·Filed 1988·Granted Jul 30, 1991·94 cites·4 claims
- 0389US6902902B2Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disordersARENA PHARM INC·Filed 2002·Granted Jun 7, 2005·34 cites·4 claims
- 0487US5008196AStimulation of endothelial cell growthMONSANTO CO·Filed 1987·Granted Apr 16, 1991·64 cites·1 claims
- 0582US6794396B2Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2003·Granted Sep 21, 2004·13 cites·14 claims
- 0677US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 0768US2007203246A1Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular IndicationsPFIZER·Filed 2007·Application pending·0 cites
- 0864US6605624B1Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 1999·Granted Aug 12, 2003·23 cites·21 claims
- 0964US6462091B1Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 1999·Granted Oct 8, 2002·15 cites·11 claims
- 1063US2005004178A1Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disordersARENA PHARM INC·Filed 2004·Application pending·0 cites
- 1162US2004220231A1Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityFiled 2004·Application pending·0 cites
- 1261US2007079392A1Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disordersARENA PHARM INC·Filed 2006·Application pending·0 cites
- 1359US2003166712A1Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 2002·Application pending·0 cites
- 1457US7611832B2Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failureARENA PHARM INC·Filed 2003·Granted Nov 3, 2009·2 cites·14 claims
- 1554US8017313B2Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disordersARENA PHARM INC·Filed 2004·Granted Sep 13, 2011·0 cites·12 claims
- 1653US2011177612A1Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related DisordersUNETT DAVID J·Filed 2010·Application pending·0 cites
- 1752US7829298B2Human G protein-coupled receptors for metabolic-related disordersARENA PHARM INC·Filed 2004·Granted Nov 9, 2010·0 cites·18 claims
- 1851US2007224127A1Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failureADAMS JOHN W·Filed 2006·Application pending·0 cites
- 1949US2007072861A1Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disordersRONIKER BARBARA·Filed 2006·Application pending·0 cites
- 2048US2009117559A1Methods for Determining Probability of an Adverse or Favorable Reaction to a Niacin Receptor AgonistLIAW CHEN W·Filed 2006·Application pending·0 cites
- 2147US2003203892A1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2244US2007232519A1Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disordersADAMS JOHN W·Filed 2006·Application pending·0 cites
- 2343US2002035156A1Combination therapy in the prevention of cardiovascular disordersFiled 2001·Application pending·0 cites
- 2442US2003125316A1Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2541US2007231263A1Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disordersQIU JUN·Filed 2006·Application pending·0 cites
- 2640US2008139628A1Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial AgonistsARENA PHARM INC·Filed 2005·Application pending·0 cites
- 2739US2008161422A1Methods and Compositions for the Treatment of Lipid-Associated DisordersKANEMITSU-PARKS MARTHA·Filed 2006·Application pending·0 cites
- 2838US4933278AMethod of determining the number of cells in cell cultureMONSANTO CO·Filed 1987·Granted Jun 12, 1990·4 cites·7 claims
- 2938US2008306114A1Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related DisordersARENA PHARM INC·Filed 2005·Application pending·0 cites
- 3035US5132214ALarge scale production of plasminogen activator from normal human colon cellsMONSANTO CO·Filed 1986·Granted Jul 21, 1992·5 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Daniel T. Connolly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →